Trial Profile
Short-term Treatment With PDE-4 Inhibitor Roflumilast or GLP-1 Agonist Liraglutide or Metformin in Treatment Naive Obese Women With Polycystic Ovary Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary) ; Liraglutide; Metformin
- Indications Obesity; Polycystic ovary syndrome
- Focus Therapeutic Use
- 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.
- 28 Jul 2014 New trial record